Indiana University
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Indiana University sits in the top decile of US sponsors by registered trial count (#38 of 15,742 sponsors by registered trial count).
Indiana University: 890 sponsored US clinical trials, 156 recruiting.
Indiana University sponsors 890 registered US clinical trials on ClinicalTrials.gov, 156 of them currently recruiting, and 561 completed. 104 of these trials are in Phase 3-4 (later-stage) and 126 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Alzheimer Disease, with 11 trials.
Top-decile sponsor footprint
Indiana University ranks in the top decile of sponsors by registered trial count (#38 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
561 of 688 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
890 total, page 9 of 18
Correlation of Renal Mass Pathologic Grade and Contrast Enhanced Ultrasound (CEUS)
NCT03821376
Gamified App on Increasing Physical Activity and Reducing Anxiety in Autism
NCT05466617
High Intensity Exercise in Incomplete SCI
NCT03714997
Physiologic Approach to Sodium Supplementation in Premature Infants
NCT03889197
Telephone Support for Metastatic Breast Cancer Patients
NCT03998618
Possible Therapy by Phone for Caregivers
NCT04634396
Validation of Indiana's Early Evaluation Hub System
NCT06586788
MOSES Lithotripsy Technology Applied to Stone Fragmentation During Ureteroscopy
NCT03995758
Diabetes Prevention Programming for Women With a History of Gestational Diabetes
NCT03971838
A Dietary Source of Potassium Citrate to Resolve Hypocitraturia and Aciduria in Patients With Kidney Stones
NCT03984409
The Surgical Education Culture Optimization Through Targeted Interventions Based on National Comparative Data - "The SECOND Trial"
NCT03739723
Everolimus Monotherapy as Immunosuppression After Liver Transplant
NCT04063865
ESP Block VS TAP in Laparoscopic Hysterectomy
NCT04003987
Alcoholic Hepatitis Network Observational Study
NCT03850899
PSMA-PET for Biopsy and Treatment Guidance in Primary Prostate Cancer
NCT03429244
Assessing Exercise Behavior and Preferences Among Patients and Oncologists
NCT04047589
Home-based SSP on Individuals With PWS
NCT03871751
Non-Invasive Cardiac Output Monitor in Children
NCT03869606
Reducing the Risk of Drug-Induced QT Interval Lengthening in Women
NCT03834883
Indiana Palliative Excellence in Alzheimer's Care Efforts
NCT03773757
Dietary Nitrate and Muscle Power With Aging
NCT03513302
Prospective Evaluation of the Incidence of PICS
NCT03584399
ShockPulse-SE vs. Trilogy Trial: Comparing the Performance of Two Intracorporeal Lithotripters for Removal of Large Renal Calculi
NCT03959683
Testing a Novel Community-based Occupational Therapy Model
NCT03855761
Effectiveness of Two Different Forms of Marine Oil on Indirect Markers of Muscle Damage and Soreness in Untrained Men
NCT03760757
Erector Spinae Block Versus Surgeon Infiltration in VATS Procedures
NCT03859635
Diabetic Foot Ulcer Recurrence: Pilot Study
NCT03479242
Supporting Trans Identities and Occupational Justice Through Narrative Informed Theatre: Supporting Trans Identities and Occupational Justice Through Narrative Informed Theatre
NCT04515654
Home-based Leg Heat Therapy
NCT03763331
MINDSpeed Food and Brain Training RCT
NCT03419052
Canine-Assisted Anxiety Reduction In Emergency Care
NCT03784573
The Hoosier Moms Cohort
NCT03696368
Feasibility, Acceptability and Preliminary Effects of the Spiritual Care Assessment and Intervention
NCT03823313
Observation of the Incidence and Natural History of MGUS in Patients Undergoing Weight Reduction Surgery
NCT03855878
On-Eye Optical Quality of Lotrafilcon B Lenses Over 12 Hours
NCT03881670
Comparison of Smoflipid to Soy-based Lipid Reduction for Cholestasis Prevention in Surgical Neonates
NCT03387579
Association Between Lactase Deficiency, and the Small Intestinal Microbiome in Adults.
NCT03860051
Intervention to Change Attributions That Are Negative (ICAN)
NCT03648476
Fasting-mimicking Diet With Chemo-immunotherapy in Non-small Cell Lung Cancer (NSCLC)
NCT03700437
Single Shot Liposomal Bupivicaine in Rotator Cuff Surgery
NCT03822182
The Role of Hypoxia on Subconcussive Head Impacts
NCT04624152
Post-resection Treatment of Large Colon Polyps
NCT03654209
Caregiver Outcomes of Alzheimer's Disease Screening
NCT03300180
An Evaluation of Tailored Messages to Address Parental Questions About HPV Vaccination
NCT03628885
Building Strength Through Rehabilitation for Heart Failure Patients (BISTRO-STUDY)
NCT03615469
Dose-response Effect of Dietary Nitrate on Muscle Function in Older Individuals
NCT03595774
Comparing Liposomal Bupivacaine Versus Standard Bupivacaine in Colorectal Surgery
NCT03702621
Chaplain Family Project Trial
NCT03702634
Narcotics Inpatient / Outpatient
NCT03728517
Heat Therapy to Reduce Pain and Improve Walking Tolerance
NCT03435835
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 56 |
| Phase 2 | 70 |
| Phase 3 | 28 |
| Phase 4 | 76 |
Therapeutic Areas
What is open in the Indiana University pipeline
156 recruiting of 890 indexed (18% open); 561 completed (63%).
Phase mix: 104 late (III/IV) vs 126 early (I/II) (balanced across stages).
Top condition: Alzheimer Disease (11 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Indiana University: open-pipeline peers nationwide
Peers matched on 890 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Indiana University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 890 trials (± recruiting share)
- University of California, Los Angeles · 897 trials · 18% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- Brigham and Women's Hospital · 937 trials · 15% recruiting
- University of Texas Southwestern Medical Center · 837 trials · 19% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Edwards Lifesciences · 18% recruiting · 57 trials
- University of South Florida · 17% recruiting · 252 trials
- VA Office of Research and Development · 17% recruiting · 1,668 trials
- ConvaTec · 18% recruiting · 17 trials
Related
What to do with this Indiana University page
890 registered trials is a research-attention snapshot, not an endorsement of Indiana University or any single study.
- 156 of Indiana University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Alzheimer Disease is the condition Indiana University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Alzheimer Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Indiana University pipeline card: 890 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.